news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

IT Home reported on August 4 that Elon Musk revealed that his brain-computer interface company Neuralink has successfully implanted the second brain-computer interface chip into a human patient. This is another major progress after the first patient was implanted in January this year.

IT Home noted that Musk shared the news on a podcast with Lex Fridman on Friday. During the eight-hour conversation, Musk mentioned that the second implant is currently going well. Musk said: "I don't want to jump to conclusions too early, but the second implant seems to be going very well.The signal is strong, there are many electrodes, and it works very well.。（I don't want to jinx it, but it seems to have gone extremely well with the second implant. So there's a lot of signal, a lot of electrodes. It's working very well）”

The implant is part of Neuralink's PRIME study, which aims to conduct clinical trials of implant technology in patients with quadriplegia caused by spinal cord injury or amyotrophic lateral sclerosis (ALS).The goal of the implant is to help patients control external devices, such as a computer mouse, using only their thoughts.

Neuralink set participant requirements last year, including no history of implanted devices, no history of epilepsy, no need for MRI examination, and no transcranial magnetic stimulation treatment.

After Neuralink received FDA approval in May last year, it implanted the brain-computer interface chip into patient Noland Arbaugh for the first time in January this year. After the implant, Arbaugh was able to control the computer mouse with his mind alone, no longer relying on his mouth and stylus.

In May, Neuralink received FDA approval to install an implant in a second patient. Musk said last month that he expects more than 1,000 people to have Neuralink chips implanted by 2026.